» Authors » Michael Eliezer

Michael Eliezer

Explore the profile of Michael Eliezer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 549
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Eliezer M, Vaussy A, Toupin S, Barbe R, Kannengiesser S, Stemmer A, et al.
Diagn Interv Imaging . 2021 Oct; 103(1):13-20. PMID: 34663547
Purpose: The purpose of this study was to prospectively evaluate image quality of three-dimensional fluid attenuated inversion recovery (3D-FLAIR) sequence acquired with a high acceleration factor and reconstructed with iterative...
22.
Guedon A, Eliezer M, Houdart E
Clin Neuroradiol . 2021 Aug; 32(2):571-575. PMID: 34463777
No abstract available.
23.
Serrano F, Guedon A, Saint-Maurice J, Labeyrie M, Civelli V, Eliezer M, et al.
Neuroradiology . 2021 Aug; 64(2):353-360. PMID: 34459945
Purpose: Endovascular treatment (EVT) has become a major option in management of infectious intracranial aneurysms (IIAs) complicating infective endocarditis. We report a retrospective, single-center series of consecutive patients with IIAs...
24.
Veillon F, Riehm S, Eliezer M, Karch-Georges A, Charpiot A, Fleury A, et al.
J Vestib Res . 2021 Jul; 31(4):251-259. PMID: 34219682
Objective: Part of the recent progress in the labyrinth imaging has been made possible by the rise of contrast-free T2-weighted and delayed (1h) FLAIR sequences. The aim of this article...
25.
Guedon A, Saint-Maurice J, Thepenier C, Labeyrie M, Civelli V, El Sissy C, et al.
J Neurosurg . 2021 May; 135(6):1636-1644. PMID: 34049278
Objective: Intracranial dural arteriovenous fistula (DAVF) is mainly treated with an endovascular approach. Two major treatment advances include transvenous embolization (TVE) with coils in 1989 and, more recently, transarterial embolization...
26.
Eliezer M, Toupet M, Housset J, Houdart E, Hautefort C
Eur Arch Otorhinolaryngol . 2021 Mar; 279(2):713-721. PMID: 33651151
Purpose: The aim of this study was to assess the rate of endolymphatic hydrops (EH) on MRI and the rate of otolithic dysfunction with cVEMP and oVEMP, in patients with...
27.
Eliezer M, Attye A, Toupet M, Hautefort C
J Vestib Res . 2021 Mar; 31(4):261-268. PMID: 33646188
Background: Since the first description by Hallpike and Cairns, the excess of endolymphatic fluid, also known as endolymphatic hydrops (EH), has been established as being the main biomarker in patients...
28.
Cornu N, Marchioni D, Eliezer M, Verillaud B, Hautefort C, Green A, et al.
Otol Neurotol . 2021 Jan; 41(10):1433-1437. PMID: 33492800
Objective: To describe the outcome and feasibility of an exclusive endoscopic transcanal transpromontorial approach (ETTA) for decompression of the labyrinthine segment of the facial nerve (LSFN). Patient: A 60-year-old man...
29.
Gargula S, Saint-Maurice J, Labeyrie M, Eliezer M, Jourdaine C, Kania R, et al.
Laryngoscope . 2020 Oct; 131(3):E775-E780. PMID: 33001464
Objective: Preoperative embolization of juvenile nasopharyngeal angiofibroma (JNA) is usually performed by the occlusion of branches of the external carotid artery (ECA). However, a significant proportion of JNAs also receive...
30.
Eliezer M, Toupet M, Guichard J, Houdart E, Kania R, Hautefort C
Otol Neurotol . 2020 Sep; 42(1):e107-e109. PMID: 32941300
No abstract available.